跳至主要内容
临床试验/NCT04306874
NCT04306874已完成不适用

High-Protein Oral Nutritional Supplementation in Patients Undergoing Pancreaticoduodenectomy

Thomas Jefferson University2 个研究点 分布在 1 个国家目标入组 22 人开始时间: 2019年8月20日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
22
试验地点
2
主要终点
Complications

研究概览

简要总结

Study investigators aim to assess the effect of providing high-protein nutritional supplementation before and after surgery

详细描述

Pancreaticoduodenectomy (PD) is a complex and morbid operation that is associated with many potential complications. Many people undergoing PD are malnourished due to their underlying medical condition or difficulties eating in the face of abdominal pain or obstruction from pancreatic disease. This study aims to assess the effect of high-protein dietary supplementation in improving perioperative nutrition and decreasing complications. We will randomize PD patients to an experimental arm in which they take a nutritional, high-protein supplement for 2 weeks before and after surgery, or to a control arm, where they will take a standard postoperative diet without supplementation. Outcomes and nutritional parameters will be examined after they complete the supplements.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients undergoing pancreaticoduodenectomy
  • Patients aged 18 years and older
  • Patients able to provide written informed consent
  • Patients able to understand and comply with study guidelines
  • Patients able to tolerate oral intake
  • Patients who are malnourished or at risk of malnutrition as defined by a score less than 12 on the Mini-Nutritional Assessment

排除标准

  • Patients with a milk protein allergy
  • Patients with a vegan diet
  • Patients dependent on artificial enteral feeding
  • Patients with end-stage renal disease undergoing dialysis
  • Patients who are pregnant
  • Patients with ongoing eating disorder or condition precluding oral intake
  • Patients who are scheduled for pancreaticoduodenectomy but are unable to receive this surgery

结局指标

主要结局

Complications

时间窗: 30 days

All complications within 30 days of surgery

次要结局

  • Overall Survival(6 months)
  • Prealbumin level(30 days)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验